Loading...
Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models
Exenatide is used to treat patients with type-2 diabetes and it also exerts cardioprotective effects. Here, we tested whether Exenatide attenuates hyperglycemia-related cardiomyocyte damage by inhibiting endoplasmic reticulum (ER) stress and the NF-κB signaling pathway. Our results demonstrated that...
Na minha lista:
| Udgivet i: | Aging (Albany NY) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7244034/ https://ncbi.nlm.nih.gov/pubmed/32392536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103181 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|